Trial Profile
Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 22 Dec 2011
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary)
- Indications Pelvic pain
- Focus Therapeutic Use
- 19 Dec 2011 Planned end date changed from 1 Nov 2010 to 1 Aug 2009 as reported by ClinicalTrials.gov.
- 19 Dec 2011 Actual patient number (9) added as reported by ClinicalTrials.gov.
- 05 Jan 2011 Planned end date changed from 1 Feb 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.